↓ Skip to main content

Dove Medical Press

Article Metrics

Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial

Overview of attention for article published in Clinical Pharmacology : Advances and Applications, February 2012
Altmetric Badge

Mentioned by

video
1 video uploader

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
45 Mendeley
Title
Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial
Published in
Clinical Pharmacology : Advances and Applications, February 2012
DOI 10.2147/cpaa.s23831
Pubmed ID
Authors

Hamid Reza Ghafarian-Shirazi, Hashemi S.N, Mohamadi A, Zadeh-Bagheri Gh, Malekzadeh M

Abstract

Depression is a common psychiatric disorder worldwide, including in Iran, and is estimated to affect 10%-15% of the population. Antidepressant drugs can have multiple side effects, so a good choice of drug is important for successful treatment. This study compared the efficacy of nortriptyline with that of fluoxetine in the treatment of patients with major depressive disorder and assessed related factors, including age, gender, and level of education.

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 45 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 22%
Researcher 6 13%
Student > Bachelor 5 11%
Other 3 7%
Student > Postgraduate 3 7%
Other 10 22%
Unknown 8 18%
Readers by discipline Count As %
Medicine and Dentistry 10 22%
Agricultural and Biological Sciences 7 16%
Psychology 6 13%
Social Sciences 4 9%
Nursing and Health Professions 4 9%
Other 4 9%
Unknown 10 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2011.
All research outputs
#5,293,586
of 6,228,821 outputs
Outputs from Clinical Pharmacology : Advances and Applications
#76
of 82 outputs
Outputs of similar age
#79,909
of 98,524 outputs
Outputs of similar age from Clinical Pharmacology : Advances and Applications
#8
of 8 outputs
Altmetric has tracked 6,228,821 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 82 research outputs from this source. They receive a mean Attention Score of 2.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 98,524 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one.